StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research note released on Wednesday. The firm issued a buy rating on the stock.
Mannatech Price Performance
Shares of MTEX stock opened at $8.88 on Wednesday. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $16.49. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The firm has a market capitalization of $16.74 million, a price-to-earnings ratio of -10.96 and a beta of 1.06. The stock’s 50-day simple moving average is $11.25 and its 200-day simple moving average is $10.07.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported $1.20 earnings per share for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Read More
- Five stocks we like better than Mannatech
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Energy Transfer: Powering Data With Dividends and Diversification
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Qualcomm Stock Is Coiling for a Breakout
- High Flyers: 3 Natural Gas Stocks for March 2022
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
